Developed by Theratechnologies, Inc. of Canada, Tesamorelin is a synthetic GHRH or growth hormone-releasing hormone. This 44-amino-acid peptide is currently used to treat HIV-associated lipodystrophy. Tesamorelin is developed from a growth hormone-releasing factor, or GHRF, and one of its main uses is to reduce excess fat around the stomach among subjects with HIV.
What Are Tesamorelin Benefits?
- FAT LOSS
- VISCERAL FAT LOSS
- ENERGY USE
- FAT METABOLISM
How Does Tesamorelin Work?
Tesamorelin stimulates the pituitary gland to release growth hormone and has been studied for its effects on growth hormone signaling and abdominal fat. Research has also examined potential effects such as muscle pain, injection-site redness, fluid retention, and numbness.
